⌘K

Login Start Free

Home/Filings/4/0001225208-25-002708

4//SEC Filing

SUSMAN SALLY 4

Accession 0001225208-25-002708

CIK 0000078003other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 5:38 PM ET

Size

10.8 KB

Accession

0001225208-25-002708

Insider Transaction Report

Form 4

Period: 2025-02-27

Senior Vice President

Transactions

Tax Payment
Common Stock
2025-02-27$26.10/sh−2,178$56,846→ 248,688 total
Tax Payment
Common Stock
2025-02-27$26.06/sh−79,779$2,079,041→ 168,909 total
Exercise/Conversion
Common Stock
2025-02-27$31.31/sh+85,182$2,667,048→ 250,866 total
Exercise/Conversion
Stock Appreciation Rights
2025-02-27−85,182→ 0 total
Exercise: $31.31From: 2025-02-27Exp: 2025-02-27→ Common Stock (85,182 underlying)

Holdings

Common Stock
(indirect: By Rule 16b-3 Plan)
866

Footnotes (4)

[F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
[F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
[F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
[F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

Documents

1 file

4
doc4.xmlPrimary

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1

filerCIK 0001263544

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 5:38 PM ET
Size: 10.8 KB

View on SEC.gov